Security key
64131A105
Neuronetics, Inc. - Common Stock, $0.01 par value (STIM)
CUSIP: 64131A105
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 53,307
- Total 13F value
- $69,415
- Share change
- -74,059
- SEC-reported price per share
- $1.30
- Number of holders
- 11
- Value change
- -$103,312
- Number of buys
- 6
- Number of sells
- 10
- Shares outstanding
- 69,571,444
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
11
Top holders
10
STIM full security history
Ownership snapshot
Full 13F holder table
Neuronetics, Inc. SEC filings
Neuronetics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 64131A105
Recent filing periods:
Ownership snapshot
Top reported holders of STIM - Neuronetics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Madryn Asset Management, LP
Disclosed value leader
Madryn Asset Management, LP
Comparable rows
15/15
Latest evidence
28 May 2026
13D/G
3/4/5
13F
Lead comparable stake: 30%
13D/G row: Madryn Asset Management, LP
Showing 1-6 of 15 holder rows.
Quick read
Madryn Asset Management, LP leads the comparable SEC ownership view at 30%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Madryn Asset Management, LP's linked filing trail.
Comparable ownership
Top 5
Madryn Asset Management, LP
30%
Jorey Chernett
15%
MADRYN HEALTH ADVISORS GP II, LLC
3.3%
MADRYN HEALTH ADVISORS II, LP
3.3%
MADRYN HEALTH PARTNERS II (CAYMAN...
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Madryn Asset Management, LP |
13D/G
3/4/5
13F
10%+ Owner · Company
|
30%
|
$32,764,556
20,737,061 shares
|
$0 | 02 Mar 2026 |
| Jorey Chernett |
13D/G
Chernett Jorey
|
15%
|
$17,308,540
10,553,988 shares
|
+$1,271,443 | 19 May 2026 |
| MADRYN HEALTH ADVISORS GP II, LLC |
3/4/5
10%+ Owner
|
3.3%
|
$3,290,155
2,269,073 shares
|
— | 28 May 2026 |
| MADRYN HEALTH ADVISORS II, LP |
3/4/5
10%+ Owner
|
3.3%
|
$3,290,155
2,269,073 shares
|
— | 28 May 2026 |
| MADRYN HEALTH PARTNERS II (CAYMAN MASTER), LP |
3/4/5
10%+ Owner
|
3.3%
|
$3,290,155
2,269,073 shares
|
— | 28 May 2026 |
| Madryn Health Partners II, LP |
3/4/5
10%+ Owner
|
3.3%
|
$3,290,155
2,269,073 shares
|
— | 28 May 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
53,307
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
99
Q2 2026 holders
11
Holder diff
-88
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend